ARCA biopharma (NASDAQ:ABIO) Coverage Initiated by Analysts

StockNews.com began coverage on shares of ARCA biopharma (NASDAQ:ABIO – Get Rating) in a report released on Monday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. ARCA biopharma Stock Performance Shares of NASDAQ:ABIO opened at $2.10 on Monday. ARCA biopharma has a 1-year low of $1.85 and a 1-year high of $2.70. […]

Related Keywords

, Murchinson Ltd , Capital Management , Renaissance Technologies , Millennium Management , Nasdaq , Vanguard Group Inc , Get Rating , Arca Biopharma , Nasdaq Abio , Fabio , Medical , Initiated Coverage , Stocknews Com ,